Stage 2 human preliminary of Oxford antibody may begin from August 26 in Pune Kumar Jeetendra | August 25, 2020 The trial may start from Wednesday, said a top official of the institute, among the 17 sites selected for the phase two human trials in the nation by Serum Institute of India (SII). “To begin with we’ve identified five volunteers who will undergo COVID-19 and antibodies test. Those whose reports are negative will be shortlisted …
Coronavirus re-contaminations raise worries about resistance Kumar Jeetendra | August 25, 2020 Two European sufferers are verified to have been re-infected with the coronavirus, raising concerns about people’s immunity to the virus since the world struggles to tame the pandemic. The cases, in Belgium and the Netherlands, follow a report this week by researchers at Hong Kong to a guy there who was re-infected using a different …
Blood Pressure may improve COVID-19 endurance rates, study says Kumar Jeetendra | August 24, 2020 Medicine for high blood pressure might improve COVID-19 survival rates, and reduce the seriousness of novel coronavirus disease, especially in patients with hypertension, according to a study. Researchers from the University of East Anglia (UEA) in the UK analyzed 28,000 patients taking antihypertensives — a category of drugs which are used to treat hypertension or …
WHO says 172 nations drawing in with worldwide COVID-19 immunization plan Kumar Jeetendra | August 24, 2020 Many 172 countries are participating with the WHO-led COVAX plan designed to ensure equitable access to COVID-19 vaccines, the World Health Organization said on Monday, but more funding is desperately needed and countries should now make binding commitments. “Initially, when there will be limited distribution (of COVID-19 vaccines), it is important to offer the vaccine …
WHO says plasma treatment still ‘trial’ Kumar Jeetendra | August 24, 2020 The World Health Organisation says using plasma by the recovered to treat COVID-19 is still considered an”experimental” therapy and that the preliminary results demonstrating it may function are still”inconclusive.” President Donald Trump on Sunday accepted an emergency authorisation of convalescent plasma for COVID-19 patients. WHO’s chief scientist Dr Soumya Swaminathan said convalescent plasma therapy was …
Study shows nasal immunization against SARS-CoV-2 inhibit contamination in mice Kumar Jeetendra | August 23, 2020 Researchers have built up an immunization that objectives the SARS-CoV-2 infection, can be given in one portion by means of the nose and is compelling in forestalling disease in mice powerless to the novel corona virus. The examiners next arrangement to test the immunization in nonhuman primates and people to check whether it is sheltered …
ICMR creating entrance for data on COVID-19 antibody Kumar Jeetendra | August 23, 2020 New Delhi, Aug 22 (PTI) The apex health research body, ICMR, is in the process of developing a vaccine portal which will offer information associated with the COVID-19 vaccine growth in India and abroad, with the majority of the upgrades in several regional languages along with English. The goal of producing the portal is to …
Self-gathered salivation and profound nasal swabs are similarly powerful for recognizing SARS-CoV-2 Kumar Jeetendra | August 23, 2020 The analysis, published in the Journal of Clinical Microbiology, signifies one of the biggest prospective specimen type comparisons to date, stated Julio Delgado, MD, MS, ARUP principal medical officer. Researchers also found that specimens self-collected in the front part of the nose are somewhat less powerful than deep nasal swabs for virus discovery. This finding …
The Native Antigen Company declares custom agreement administration to create flu An and B antigens Kumar Jeetendra | August 23, 2020 The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), among the world’s leading suppliers of reagents which enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the debut of its custom contract agency to rapidly develop antigen panels for influenza A and B viruses. This new service provides …
AnteoTech’s COVID-19 antigen and Flu A&B test distinguishes SARS-Cov-2, flu in under 15 minutes Kumar Jeetendra | August 23, 2020 AnteoTech Ltd has developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests which could detect the existence of SARS-Cov-2 and influenza in under 15 minutes. The tests utilize AnteoTech’s patented AnteoBind™ activated europium technologies and provide considerably higher sensitivity than that provided by currently available COVID-19 tests. AnteoTech intends for the tests to …
Kids are quiet spreaders of COVID-19: Study Kumar Jeetendra | August 21, 2020 Kids play a larger part in the community spread of COVID-19 than previously thought, according to a study which found that the younger individuals might not be as inclined to become seriously sick as adults, but they can spread infection and bring the virus into their houses. The study, published in the Journal of Pediatrics, …
Gargled water tests might be feasible option in contrast to swabs for identification of COVID-19: Study Kumar Jeetendra | August 21, 2020 Gargled water samples might be a feasible alternative to swabs for detection of COVID-19, enabling easy self-collection and taking away the need for trained health care workers for sample collection, according to a study published at the ICMR’s Indian Journal of Medical Research. Adoption of gargle lavage for sample group will have a significant effect …
